Disclosure Panels Details Page
CLL/SLL/Hairy Cell Leukemia Panel - Disclosures as of 01/26/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Jeremy Abramson MD, MMSc | Juno Lam therapeutics Pharmacyclics Seattle Genetics Unum |
Celgene Corporation Genentech, Inc. Gilead Novartis Pharmaceuticals Corporation Seattle Genetics |
None | None | - |
| Syed Bilgrami MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Greg Bociek MD, MSc | None | None | None | None | ✔ |
| Danielle Brander MD | Novartis Pharmaceuticals Corporation | Abbott Laboratories Teva TG Therapeutics |
None | None | - |
| Jennifer Brown MD, PhD | Morphosis | AbbVie, Inc. Genentech, Inc. Gilead, Inc. Janssen Pharmaceutica Products, LP Pharmacyclics TG Therapeutics Verastem |
None | None | ✔ |
| John Byrd MD | None | None | Acerta Pharma Genentech, Inc. Janssen Pharmaceutica Products, LP Pharmacyclics |
None | ✔ |
| Asher Chanan-Khan MD | Millennium Pharmaceuticals, Inc. | Millennium Pharmaceuticals, Inc. | None | None | - |
| Alycia Corrigan | None | None | None | None | - |
| Steven Coutre MD | AbbVie, Inc. Acerta Pharma BeiGene Celgene Corporation Gilead Janssen Pharmaceutica Products, LP Pharmacyclics Takeda Pharmaceuticals North America, Inc. |
Celgene Corporation | AbbVie, Inc. Genentech, Inc. Gilead Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Pharmacyclics |
None | ✔ |
| Randall Davis MD | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Christopher Fletcher MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Brian Hill MD, PhD | Novartis Pharmaceuticals Corporation Pharmacyclics |
Genentech, Inc. Gilead Pharmacyclics |
Celgene Corporation | None | ✔ |
| Brad Kahl MD | Cell Therapeutics, Inc. Millennium Pharmaceuticals, Inc. Roche Laboratories, Inc. Seattle Genetics |
AbbVie, Inc. Acerta Pharma Astellas Pharma US, Inc. Genentech, Inc. juno Pharmacyclics |
None | None | - |
| Manali Kamdar MD | None | Pharmacyclics | Seattle genetics | None | ✔ |
| Lawrence Kaplan MD | None | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Nadia Khan MD | Bristol Myers Squibb Fox Chase Cancer Center |
None | Genentech, Inc. | None | - |
| Thomas Kipps MD, PhD | AbbVie, Inc. Acerta Pharma AstraZeneca Pharmaceuticals LP Celgene Corporation CIRM Gilead Infiniti Pharmaceuticals Janssen Pharmaceutica Products, LP Juno miRagen Oncternal Pharmacyclics Portola Roche/ Genentech |
AbbVie, Inc. Dava Oncology Janssen Pharmaceutica Products, LP Pharmacyclics TG Therapeutics |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP Dava Oncology Pharmacyclics Verastem |
None | - |
| Jeffrey Lancet MD | Bipath Holdings Daiichi- Sankyo Co. Pfizer Inc. Prescient Therapeutics |
Astellas Pharma US, Inc. Asterias Baxalta Biosight Biosight Pharmaceuticals Celgene Corporation Daiichi- Sankyo Co. Janssen Pharmaceutica Products, LP Jazz Pharmaceuticals Novartis Pharmaceuticals Corporation |
None | None | - |
| Shuo Ma MD, PhD | NA | NA | NA | NA | ✔ |
| Sami Malek MD | Janssen Pharmaceutica Products, LP Pharmacyclics |
Daiichi- Sankyo Co. Genentech, Inc. Gilead Pharmacyclics |
None | Portola | - |
| Joan McClure MS | None | None | None | None | - |
| Claudio Mosse MD, PhD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Mazyar Shadman MD, MPH | None | Abbott Laboratories Genentech, Inc. |
None | None | ✔ |
| Tanya Siddiqi MD | AbbVie, Inc. Acerta Pharma Boehringer Ingelheim GmbH City of Hope Genentech, Inc. Juno Kite pharma MedImmune Inc. Merck & Co., Inc. Pharmacyclics Seattle Genetics TG therapeutics |
None | Juno Pharmacyclics Seattle Genetics |
None | - |
| Jack Skinner PhD | None | None | None | None | - |
| Deborah Stephens DO | None | Alexion Pharmaceuticals, Inc. | None | None | - |
| Hema Sundar PhD | None | None | None | None | ✔ |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Amanda Visnick BSN, RN, OCN | None | None | None | None | - |
| Nina Wagner-Johnston MD | Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Seattle Genetics |
Juno Therapeutics | None | None | ✔ |
| William Wierda MD, PhD | AbbVie, Inc. Ascerta Genentech, Inc. Gilead GSK/Novartis Juno Therapeutics Kite Pharma MiRagen Therapeutics, Inc. Oncternal Therapeutics, Inc. Pharmacyclics Sunesis Pharmaceuticals, Inc. Xencor, Inc. |
sanofi-aventis U.S. | None | None | ✔ |
| Andrew Zelenetz MD, PhD | AbbVie, Inc. BeiGene Genentech, Inc. Gilead MEI Pharmaceuticals |
Adaptive Biotechnology Adaptive Biothechnologies Corp Amgen Inc. Celgene Corporation Genentech, Inc. Gilead Hoffman La Roche NanoString Technologies Pharmacyclics Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |